Lipids: how do we convert experimental data to policy?

被引：1

作者：

Deckelbaum, RJ

Calder, PC

机构：

[1] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA

[2] Columbia Univ, Dept Pediat, New York, NY 10032 USA

[3] Univ Southampton, Inst Human Nutr, Southampton, Hants, England

来源：

CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE | 2005年 / 8卷 / 02期

关键词：

D O I：

10.1097/00075197-200503000-00002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：113 / 114

页数：2

共 4 条

[1] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[2] Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL [J].

Cheung, MC ;

Zhao, XQ ;

Chait, A ;

Albers, JJ ;

Brown, BG .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) :1320-1326

[3]

De Luca LM, 1996, NUTR REV, V54, P178, DOI 10.1111/j.1753-4887.1996.tb03926.x

[4]

MILLER ER, 2004, ANN INT MED 1110

← 1 →